Cite
HARVARD Citation
Poullenot, F. et al. (2022). Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator: a Multicentre Cohort Study. Journal of Crohn's and colitis. pp. 1523-1530. [Online].